BMC Pharmacology and Toxicology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 62.6% | 0.752 | Q2 | 75.3% |
| 2024 | 2.7 | Q2 | 53.8% | 0.814 | Q2 | 78.4% |
| 2023 | 2.8 | Q2 | 52.4% | 0.710 | Q2 | 76.2% |
| 2022 | 2.9 | Q3 | 46.9% | 0.603 | Q2 | 72.2% |
| 2021 | 2.6 | Q4 | 25.8% | 0.497 | Q3 | 66.9% |
| 2020 | — | — | 0.618 | Q2 | 72.6% | |
| 2019 | — | — | 0.612 | Q2 | 73.2% | |
| 2018 | — | — | 0.870 | Q2 | 80.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2050-6511
country
coverage
2012-2026
